PO23-729 THE SYNERGISTIC EFFECT OF FLUVASTATIN AND EZETIMIBE ON HS-CRP LEVELS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AT HIGHER CARDIOVASCULAR RISK | Publicación